| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911040 | Lung Cancer | 2013 | 6 Pages |
Abstract
Gefitinib rechallenge and BPD played a central role in long term survival of the patients who initially responded to gefitinib.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
K. Nishino, F. Imamura, S. Morita, M. Mori, K. Komuta, T. Kijima, Y. Namba, T. Kumagai, S. Yamamoto, I. Tachibana, Y. Nakazawa, J. Uchida, S. Minami, R. Takahashi, Y. Yano, T. Okuyama, A. Kumanogoh,